&w=3840&q=100)
This smallcap IT stock jumps 7% on order win today; here's why
The stock was up 6.2 per cent at ₹136.95 compared to the previous day's close of ₹128.95 on the BSE, as of 12:30 PM. In comparison, the benchmark BSE Sensex was trading at 82,300 levels, up 100 points or 0.12 per cent. Last checked, the company's total market capitalisation stood at ₹151.38 crore. Atishay stock is up over 15 per cent from its 52-week low of ₹120.3, touched on August 29, 2024. However, on a year-to-date (YTD) basis, the stock has plunged over 38 per cent.
In an exchange filing on Tuesday, the company informed that it has received a five-year rate contract from the State Election Commission of Karnataka. "The contract has been awarded to a consortium led by Atishay (Prime Bidder) and Gundal Business (Consortium Partner)," the company said.
According to the filing, the scope of the work involves 'Preparation (Generation, Integration & Merging of Electoral Database) and Printing of Photo Electoral Rolls & Other Printing Works activities in connection with local body elections across 31 districts in the state of Karnataka.
Work orders will be issued by the authority as per the requirement, the company said. The contract is valid till July 20, 2030.
In addition, the contract is rate-based, with no fixed monetary value assigned at the outset. "The total consideration will depend on actual work orders placed during the contract period. However, given the scale and scope, the expected potential value is significant," the company said.
Atishay financial snapshot
In the March 2025 quarter (Q4FY25), the company has reported a total revenue of ₹12.84 crore and net profit of ₹2.37 crore. In the fiscal 2024-25 (FY25), the company revenue stood at ₹51.15 crore and net profit of 7.01 crore.
About Atishay
Incorporated in March 2000, Atishay offers a wide range of information technology, database management and e-governance services, including large-scale data entry and scanning solutions, digitisation services, document conversion, and database management to the PSUs and government entities. Currently, the company provides services in the states of Maharashtra, Rajasthan, Uttar Pradesh, Bihar and Madhya Pradesh.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
27 minutes ago
- Business Standard
ADAG stocks, Reliance Infra, Reliance Power hit lower circuits; here's why
Reliance Infrastructure, Reliance Power share price today Shares of Anil Dhirubhai Ambani Group (ADAG) companies, Reliance Infrastructure (₹360.05) and Reliance Power (₹59.70), were locked in the 5-per cent lower circuit on the BSE in Thursday's intraday trade amid reports of Enforcement Directorate (ED) raids across 35 locations linked to Reliance Anil Ambani Group in money laundering probe. Till 12:41 PM; a combined 1.48 million equity shares changed hands on Reliance Infrastructure counter. There were pending sell orders for 1.3 million shares on the NSE and BSE. On the Reliance Power counter there were pending sell orders for 7.53 million shares on the NSE and BSE. A combined 12.18 million shares changed hands, the exchange data shows. Currently, Reliance Infrastructure and Reliance Power are trading under 'T' or Trade-for-Trade (T) group on the BSE. The T group is a surveillance measure that requires securities to be settled on a trade-to-trade basis. Meanwhile, the stock price of Reliance Infrastructure (up 143 per cent) and Reliance Power (up 184 per cent) had zoomed more than 100 per cent from their respective 52-week lows touched on July 24, 2024. According to a Business Standard report, the Enforcement Directorate (ED) on Thursday raided several locations connected to Anil Ambani as part of its ongoing investigation into the Yes Bank loan fraud case. ED's action came in after State Bank of India (SBI) decided to classify telecom company Reliance Communications as 'fraud' and will report its former director, Anil Ambani, to the Reserve Bank of India (RBI). The ED is currently examining over 50 companies and 25 individuals believed to be part of the network. Meanwhile, Reliance Infrastructure in its FY25 annual report said that during the financial year 2020-21, the company, as a part of settlement with Yes Bank Limited, had sold its investment including Property, plant and equipment at Santacruz at a total transaction value of ₹1,200 crore through the conveyance deed entered with Yes Bank Limited. The company is entitled to exercise its rights/option to buy back this property after 8.5 years from the date of sale, subject to fulfillment of the condition precedents at an agreed price as per option agreement entered between parties. Business Overview Reliance Infrastructure is a diversified infrastructure company, primarily engaged in providing comprehensive engineering & construction (E&C) services across multiple sectors including power, transportation, urban infrastructure and defence. Multiple projects are undertaken through Special Purpose Vehicles (SPVs), permitting focused execution and efficient management. Reliance Power, a constituent of the Reliance Group, is a prominent private sector power generation company in India. The company has built a diversified portfolio encompassing thermal, solar and hydroelectric power projects, with the objective of developing, constructing and operating power projects both domestically and internationally. The company is in the business of developing and operating power generation projects, along with the development of coal mines linked to these projects. Reliance Power has built a balanced portfolio including both power plants and coal assets. As of now, power projects with a total capacity of approximately 5,305 MW have been successfully commissioned, while the remaining projects are at different stages of planning and development.
&w=3840&q=100)

Business Standard
27 minutes ago
- Business Standard
Motilal Oswal Q1 FY26 result: Profit up 32% at ₹1,162 crore, revenue 18%
Motilal Oswal Financial Services also swung back to profit from a ₹64.77 crore loss in the previous quarter Rahul Goreja New Delhi Motilal Oswal Financial Services on Thursday reported a net profit of ₹1,162.06 crore for the first quarter of the financial year 2026, up 31.7 per cent from ₹881.89 crore a year ago. The company also swung back to profit from a ₹64.77 crore loss in the previous quarter. The company's revenue from operations rose 18.3 per cent year-on-year (Y-O-Y) at ₹2,737.03 crore and more than doubled sequentially, rising 129.9 per cent from ₹1,190.26 crore. Shares of Motilal Oswal were trading at ₹928.9 apice on the BSE at 1.22 pm on Thursday
&w=3840&q=100)

Business Standard
27 minutes ago
- Business Standard
Senores Pharma hits all time high on posting Q1 results; PAT up 95% YoY
Senores Pharmaceuticals shares touched an all-time high in trade, gaining 15.6 per cent in trade on BSE. The buying on the counter came after the company posted its Q1 results. At 12:27 PM, Senores Pharma share price was trading 13.16 per cent higher at ₹690 per share on BSE. In comparison, BSE Sensex was down 0.64 per cent at 82,195.32. Senores Pharmaceuticals Q1 results Senores Pharma reported its Q1FY26 results on Wednesday, after market hours. In the June quarter (Q1FY26), the company registered a 94.6 per cent fall in the consolidated net profit year-on-year (Y-o-Y) to ₹21.2 crore as compared to ₹10.9 crore. Its revenue from operations grew 64 per cent to ₹130.3 crore, from ₹79.5 crore a year ago. The company reported an Earnings before interest, tax, depreciation and amortisation (Ebitda) at ₹34.2 crore, as compared to ₹21.3 crore, up 60.3 per cent Y-o-Y. However, Ebitda margins stood at 24.8 per cent, as against 26.5 per cent. For Q1FY26, the regulated markets revenue stood at ₹90 crore, growing by 69 per cent Y-o-Y. Emerging markets revenue stood at ₹29 crore, growing by 32 per cent Y-o-Y. The company launched two own abbreviated new drug application (ANDA) products in the Regulated Markets during the quarter. It also received the ANDA approval for four products during the quarter. 'We have a strong pipeline in place which we will launch over the next couple of years,' said Swapnil Shah, managing director, Senores Pharmaceuticals. He added: Our business is undergoing a structural advancement which will provide better market visibility and support the growth momentum for us over the medium term to the longer term. We will continue to drive the business on three key pillars – Expansion of the ANDA portfolio in regulated markets, Steady Scale-up of the CDMO/CMO Segment in Regulated Markets; and portfolio expansion and profitability Improvement in emerging markets. About Senores Pharmaceuticals Senores Pharmaceuticals Limited is a global research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms. The companies' current portfolio includes 24 ANDA and 27 CMO/CDMO commercial products that are permitted for distribution in the USA. Senores is also engaged in the development and manufacturing of complex generics certified by global food and drugs authorities and delivers generic drugs for emerging markets catering to more than 40 countries.